Humacyte Inc.

NASDAQ: HUMA · Real-Time Price · USD
1.89
0.01 (0.53%)
At close: Aug 15, 2025, 3:59 PM
1.91
1.33%
After-hours: Aug 15, 2025, 06:21 PM EDT

Humacyte Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
8.05M 7.75M 7.23M 10.79M 10.79M 10.79M 10.79M n/a 31K 1.33M 1.56M 1.74M 1.95M 1.34M 1.26M 1.21M 1.88M 1.39M
Cost of Revenue
7.62M 9.23M 9.04M 8.8M 8.31M 8.48M 8.77M 7.52M 8.25M 20.91M 20.88M 18.8M 16.8M 2.39M 15.48M 28.63M 43.27M 54.85M
Gross Profit
428K -1.48M -1.81M -8.8M -8.31M -8.48M -8.77M -7.52M -8.22M -19.58M -19.31M -17.06M -14.85M -1.05M -14.22M -27.42M -41.39M -53.46M
Operating Income
-111.23M -111M -114.4M -112.49M -106.88M -104.11M -100.05M -94.66M -93.53M -85.33M -84.58M -85.42M -82.46M -83.2M -81.21M -75.25M -71.92M -67M
Interest Income
3.26M 3.73M 4.1M 4.4M 4.85M 5.02M 5.47M 5.74M 5.25M 4.07M 2.63M 1.23M 345K 46K 16K 7K 6K 533K
Pretax Income
-58.66M -77.67M -148.7M -152.87M -139.66M -105.7M -110.78M -89.39M -88.68M -29.1M -11.96M 34.34M 28.06M -26.01M -26.48M -85.27M -71.47M -69.15M
Net Income
-58.66M -77.67M -148.7M -152.87M -139.66M -105.7M -135.65M -96.97M -96.4M -36.83M 8.55M 37.56M 31.42M -22.64M -26.48M -85.27M -71.47M -69.15M
Selling & General & Admin
34.3M 30.41M 25.8M 17.38M 16.14M 15.3M 17.01M 20.22M 20.34M 22.43M 22.88M 22.6M 21.81M 22.02M 21.13M 18.17M 16.21M 13.54M
Research & Development
81.01M 82.75M 88.6M 88.12M 83.75M 80.54M 76.55M 71.33M 70.11M 64.22M 63.26M 64.55M 62.6M 62.52M 61.34M 58.29M 57.6M 54.85M
Other Expenses
-3.43M -3.64M -1.81M -1.81M -1.31M -1.31M -1.58M -1.63M -345K -345K -312K -264K -1.49M -1.49M -1.41M -1.41M -155K -155K
Operating Expenses
111.87M 109.52M 112.59M 103.69M 98.57M 94.52M 92.25M 90.23M 90.42M 85.33M 84.58M 85.42M 82.46M 83.2M 81.21M 75.25M 71.92M 55.38M
Interest Expense
5.4M 10.46M 9.28M 8.5M 7.52M 6.72M 6.6M 6.51M 6.69M 6.47M 6.2M 5.96M 5.52M 5.25M 4.35M 3.49M 2.84M 1.62M
Selling & Marketing Expenses
3.61M 1.79M n/a -6.99M -6.99M -5.17M -3.38M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
119.28M 118.75M 121.63M 112.49M 106.88M 101.01M 96.94M 91.55M 90.42M 85.33M 84.58M 85.42M 82.46M 83.2M 81.21M 75.25M 71.92M 67.2M
Income Tax Expense
n/a n/a n/a n/a n/a n/a 24.88M 7.58M 7.73M 7.73M -20.51M -3.22M -3.36M -3.36M 1K 1K 1K 1K
Shares Outstanding (Basic)
155.44M 131.5M 118.48M 119.41M 119.17M 108.25M 103.61M 103.44M 103.36M 103.26M 103.16M 103.03M 103.01M 103M 103M 43.95M 103M 103M
Shares Outstanding (Diluted)
155.44M 131.76M 118.48M 119.41M 119.17M 108.25M 103.61M 103.44M 103.36M 103.26M 103.16M 103.03M 103.91M 103M 104.74M 43.95M 103M 103M
EPS (Basic)
-0.45 -0.69 -1.26 -1.34 -1.26 -1 -1.31 -0.94 -0.94 -0.36 0.08 0.36 -0.11 -0.64 -0.68 -6.7 -7.41 -7.92
EPS (Diluted)
-0.45 -0.69 -1.26 -1.34 -1.26 -1 -1.31 -0.94 -0.94 -0.37 0.07 0.35 -0.12 -0.64 -0.68 -6.7 -7.41 -7.92
EBITDA
-37.33M -59.93M -132.19M -135.57M -123.83M -90.51M -95.4M -113.31M -111.69M -52.3M -35.46M 48.48M 41.22M -16.37M -17.72M -77.36M -63.63M -58.68M
EBIT
-50.72M -67.2M -139.42M -144.37M -132.14M -98.99M -104.18M -82.88M -81.99M -22.64M -5.76M 40.3M 33.58M -24.05M -25.42M -85.07M -71.92M -67M
Depreciation & Amortization
5.45M 7.28M 7.23M 8.8M 8.31M 8.48M 8.77M 7.52M 8.25M 8.29M 8.26M 8.19M 7.64M 7.67M 7.69M 7.71M 8.29M 8.32M